Active Substance Master File (ASMF) worksharing procedure

Similar documents
1 The EU Harmonised technical ectd guidance version 4.0

Annex 2 to the HMA esubmission Roadmap: Implementation of mandatory use of ectd format for regulatory submissions

The place of the Certification procedure in 2017 in the EU regulatory framework and beyond. Prague, 19 September 2017

esubmission roadmap v2.0: Industry viewpoint

Recommendation on duplicate applications in mutual recognition and decentralised procedures

CMDv/BPG/002. BEST PRACTICE GUIDE for Veterinary Decentralised Procedure (DCP)

BEST PRACTICE GUIDE FOR DECENTRALISED AND MUTUAL RECOGNITION PROCEDURES

Report from the CMDh meeting held on November 2013

Report on status of on-going Article 45 & 46 work-sharing procedure. Shirley NORTON MHRA (UK) Alban DHANANI AFSSAPS (FR)

The New EU PV Legislation: View from the European Commission

EDQM roadmap for electronic submissions

PSUR and PSUR repository. Legal basis. PSUR/PBRER General comments

Standard operating procedure

Adopted by Pharmacovigilance Risk Assessment Committee 20 February Adopted by Pharmacovigilance Inspectors Working Group 21 March 2014

General FAQ relating to e-submission for Veterinary Applications

Guide to Renewal of Veterinary Product Authorisations

...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS

Guideline on good pharmacovigilance practices (GVP)

Article 29(1) Referral

Implementation of the new pharmacovigilance legislation: Overall update and activities in 2013

Detailed guidance for National Scientific- Technical Advice (STA) requests:

Good Pharmacovigilance Practice. Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA

Overview of ICH. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

NEW FRAMEWORK FOR SCIENTIFIC ADVICE & PROTOCOL ASSISTANCE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Feedback on SADC Workshop of Industry & Regulators. Luther Gwaza PhD Consultant

Questions and answers on the procedure of PIP compliance verification at EMA, and on paediatric rewards

Reflection Paper on Medicinal Product Supply Shortages Caused by Manufacturing/GMP Compliance Problems. Outcome of 10 September 2012 Workshop

Trends in the development of regulatory systems by the example of ICH countries

Guidance for applicants requesting scientific advice

***I DRAFT REPORT. EN United in diversity EN. European Parliament 2018/0018(COD)

Standard operating procedure

5.1 Demonstration Segment: Using the Workflow

Work plan for GCP Inspectors Working Group for 2018

Safeguarding public health. The New PV Legislation. Perspective from a Member State

STANDARD OPERATING PROCEDURE

Maintenance Review Board PR.MRB

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

DRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy

STANDARD OPERATING PROCEDURE

Procedure for handling applications for authorisation and review reports under REACH

SADC Collaborative Medicines Registration Initiative (Zazibona)

ECHA and the implementation of REACH,CLP and other tasks

Electronic submission of information on medicinal products in accordance to Article 57(2) requirements: Maintenance submission

Implementation of REACH & CLP: common challenges of national authorities and ECHA

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Applicants are reminded that the

The implementation of the Clinical Trial Regulation (CTR, n 536/2014) in Belgium. and impact on the ethical review process

Guideline on good pharmacovigilance practices (GVP)

CLP the implementation of GHS in the EU Facts and practical advice

INTERNATIONAL CONSULTATION AND ANALYSIS

Safeguarding public health. The New PV Legislation its Impact on PV & MI

European CE Marking of Medical Devices. October 2017

- Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Safety of the food chain Chemicals, contaminants, pesticides

Questions and answers about Recycling Processes

Topical Peer Review 2017 Ageing Management of Nuclear Power Plants

STANDARD OPERATING PROCEDURE

Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo

Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force

Role of the Nursing Home Medical Director. Vicky Pilkington, MD, CMD

Biocidal product regulation the changes to come

Intra-Africa Academic Mobility Scheme. Workshop 2 Promotion and Selection EACEA A.3. Elena PALAVROVA

Lessons from the EMA Patient Registries Initiative

EUROPEAN COMMISSION. CALL - EAC/A06/2017 Erasmus+ Vocational Education and Training Mobility Charter

Health and Safety Authority. Function and Scope of REACH and CLP Helpdesks

Regulation 347/2013 as adopted and adapted in the Energy Community

Market Access for Food Supplements: EHPM Country Profiles. Mr Patrick Ahern Director General EHPM

Application Form. Green Infrastructure Fund

Technical Report No. 68 Risk-Based Approach for Prevention and Management of Drug Shortages

Final Draft Agenda Sixteenth meeting of the Forum for Exchange of Information on Enforcement (Forum-16) October 2013

ASSEMBLY AGENDA PAPERS. May 31 & June 1, 2017 Montreal, Canada

Improving Care and Lowering Costs for Dual Eligible Beneficiaries

GUIDE FOR ACTION GRANTS 2015

Accelerated procedure for registration of WHO-prequalified medicines = Collaboration Procedure between the WHO Prequalification Programme and NMRAs

European Maritime Safety Agency. Training on Maritime Security October Obligations for. Maritime Administrations

BETTER REGULATION OF MEDICINES INITIATIVE (BROMI): FIFTH REPORT ON PROGRESS

European IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals

Integration Scheme. Between. Glasgow City Council. and. NHS Greater Glasgow and Clyde

Application Form Green Infrastructure Fund

Guidance on the Biocidal Products Regulation

The Classification and Labelling Inventory. Cefic s viewpoint

A Dedicated Post Authorisation Measure Submission Form

REPUBLIC OF SERBIA Bilateral screening: Chapter 1 Free Movement of Goods. C L P Classification, Labeling and Packaging of substances and mixtures

Opinion No 13/2016. Technical records

Guidance notes for patient safety and pharmacovigilance in patient support programmes

Knowledge Exchange and Dissemination Scheme

Guidance on the preparation of dossiers for harmonised classification and labelling (CLH) under Regulation (EC) No.

Bilateral screening: Chapter 27 PRESENTATION OF THE REPUBLIC OF SERBIA Classification, labelling and packaging of substances and mixtures - CLP

ICH Topic Q4B Annex 6 Uniformity of Dosage Units General Chapter. Step 3

Page 1 of 5 Version No: 6 Authorised by: General Counsel

ASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

What s Next for CMS Innovation Center?

State Policy Update. Liz Parry and Linda Shaw

TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES

Regulatory Conference: KEY TAKE- AWAYS. Engela Dedwith, Eli Lilly

SUMMARY OF THE INDUSTRY TASK GROUP MEETING HELD AT 08:00 ON 23 JUNE 2015 IN THE CIVITAS BUILDING

Transcription:

Active Substance Master File () worksharing Working Group Nienke Rodenhuis September 2017 1 Table of Contents Why needed History How does it work Status Support 2 2

Why do we need a worksharing for s? When the same is used in multiple s and/or Member States, it can lead to Duplicated Divergent decisions Frequent updates (at NCA request) Reduced oversight of the Increased workload (all parties) 3 3 What has been done to solve the problem? Assessment Worksharing Procedure A simple way for Competent Authorities to share report for the same version of the Letter of Access 1 Submission Details Form 2 report repository EU/ repository number 1 Annex 2 and 2 Annex 3 of CHMP/QWP/227/02 Rev 3/Corr Guideline on the 4 4

History Goal: There should be 1 for Used in national, MRP/DCP and CP, variations For human & veterinary products April 2010 : discussion in HMA June 2010 : first meeting of -WG April 2011 : meeting with interested parties and HMA decision December 2013 : start of pilot-phase January 2017 : end of pilot-phase, worksharing is business as usual 5 5 Collaboration Members: All EU national competent authorities Observers : EDQM, IGDRP Continuous interaction with stakeholders At QWP plenary meetings (intra-network) At bimonthly WG meetings (intra-network) holders taking part in WS and Interested Parties (AESGP, EFPIA, EGA, EUCOPE, APIC/CEFIC, IFAH, EGGVP) 6 6

How does the worksharing work? EU/ repository number + Submission Details Form Tracks where the same version of the is used in different s & Member States report repository allows Competent Authorities to share easily the report ( holder acknowledges sharing of reports in the Letter of Access) 7 7 How does the worksharing work? Designed to operate within existing legislation, regulatory s and timetables NO IMPACT ON PROCEDURE TIMINGS Reduces CA requests for updates Harmonises Improves oversight of the Reduces workload & MA holders (plus Competent Authorities) 8 8

The worksharing Includes New s submitted in DCP, CAP or national marketing authorisation applications and variation applications Undergoing / previously assessed in a DCP/MRP/CAP NB: s undergoing or have been assessed in national only s may still be accepted in the worksharing, but may result in a new evaluation of the. holders should list these applications in the Submission Details Form so that the report may be requested and used in the evaluation. NB: If the same data have been submitted in a CEP application, holders should notify Competent Authorities so that the report may be requested from the EDQM Updates to a worksharing can be submitted in a MA or MAV application using any regulatory in order to preserve its lifecycle Use of the is strongly recommended, but not mandatory 9 9 The worksharing Assessments of new s composed of 2 to 3 stages -AR repository uses timetables to identify parent Other s are Daughter s Parent is responsible for drafting report QA review of the report by Parent CMS/Daughter RMS Review of report by Parent CMS Only Major Objections raised during reviews Procedure repeats as above until is complete 10 10

Current number of s in Worksharing Status August 2017: Number of -numbers issued : 128 Accepted for use ( finalised) : 40 Under evaluation : 58 Reserved : 26 s withdrawn : 4 11 11 What support is available? Relevant to worksharing and worksharing s Applicable to all s Assessment worksharing guidance Guidance on CMD Q&As on worksharing Training on the worksharing CMD Q&As on Additional guidance on documents Completing & submitting annex 2, 3 & 4 12 12

Links to support documents Guideline on the (CHMP/QWP/227/02/Rev3/Corr) http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webcontentid=wc500129994 Additional guidance on documents relating to an active substance master file http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webcontentid=wc500133204 CMD Q&As on the + Q3.4 of the CMD Q&A on Variations (concerning updates) The worksharing Training material on the worksharing CMD Q&As on the worksharing 13 13 What support is available? For issues concerning the work sharing, please contact the CMD Working Group on s H-CMDhSecretariat@ema.europa.eu The subject header of the email should clearly state worksharing 14 14